Anzeige
Meldung des Tages: US-Goldprojekt vor dem Durchbruch: Warum Investoren jetzt aufmerksam werden

Bavarian Nordic News

Aktie
WKN:  917165 ISIN:  DK0015998017 US-Symbol:  BVNKF Branche:  Biotechnologie Land:  Dänemark
26,69 €
+0,55 €
+2,10%
13.04.26
Depot/Watchlist
Marktkapitalisierung *
1,97 Mrd. €
Streubesitz
70,67%
KGV
15,06
Nachhaltigkeits-Score
70 %
Index-Zuordnung
-

Bavarian Nordic News

27.03.26 - GlobeNewswire
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years
Submission based on topline data from clinical study, demonstrating a comparable safety profile and a non-​inferior immune response for MVA-BN in children aged 2-11 years ...
12.03.26 - GlobeNewswire
Bavarian Nordic Publishes Annual Report 2025
COPENHAGEN, Denmark, March 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) today published its annual report for 2025. The consolidated, audited results were in line with the ...
11.03.26 - GlobeNewswire
Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-​income countries. Expanded collaboration provides future co-...
02.03.26 - GlobeNewswire
Paul Chaplin Steps Down as CEO of Bavarian Nordic
COPENHAGEN, Denmark, March 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today, that the Board of Directors has entered into an agreement with CEO, Paul Chaplin, ...
18.02.26 - GlobeNewswire
Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada
COPENHAGEN, Denmark, February 18, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced a new order valued at USD 22.5 million from the Public Health Agency of Canada ...
12.02.26 - GlobeNewswire
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public Preparedness. 2026 guidance reflects ...
23.01.26 - GlobeNewswire
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
Agreement to enable the first entry in Latin America for Bavarian Nordic’s chikungunya vaccine Potential to expand agreement to cover rest of Latin America COPENHAGEN, ...
17.12.25 - GlobeNewswire
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of ...
02.12.25 - GlobeNewswire
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to ...
26.11.25 - GlobeNewswire
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen
COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will ...
14.11.25 wallstreetONLINE Redaktion
Biotech unter Druck: Zahlen top, Aktie flop: Bavarian Nordic rutscht ins Minus!
Bavarian Nordic steigert Umsatz und Ergebnis deutlich und präzisiert die Jahres­prognose, doch die Aktie rutscht ab. Ein überraschender Rückzug sorgt für Unruhe.Das dänische ...
14.11.25 - GlobeNewswire
Bavarian Nordic Announces Interim Results for the First Nine Months of 2025
COPENHAGEN, Denmark, November 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2025 and business ...
13.11.25 - GlobeNewswire
Bavarian Nordic Announces Changes to the Board of Directors
COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board ...
01.11.25 - GlobeNewswire
Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority ...
31.10.25 - GlobeNewswire
Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox
New and larger framework contract with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) replaces previous agreement and provides ...
28.10.25 - GlobeNewswire
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in ...
07.10.25 - GlobeNewswire
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
Primary endpoint was met in clinical study, demonstrating a comparable safety profile and a non-​inferior immune response for MVA-BN in children aged 2-11 years compared to ...
22.08.25 wallstreetONLINE Redaktion
Gewinne ziehen an: Kurz vor Milliarden-Deal: Dieses Biotech-Unternehmen sprengt die Erwartungen
Starke Umsätze und steigende Gewinne stärken die Position des Impfstoffherstellers Bavarian Nordic. Kurz vor dem Milliarden-​Deal wächst die Spannung.Der dänische ...
22.08.25 - GlobeNewswire
Bavarian Nordic Announces First Half 2025 Results
COPENHAGEN, Denmark, August 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2025 and ...
31.07.25 - GlobeNewswire
Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance
COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the ...

Newssuche

Videos

newspaper
07.04.26 +5,47%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »